Launching healthcare products in France

Discover key facts about the healthcare market in France and learn about our latest market research for our pharmaceutical, medical device, and healthcare sector clients.

Key facts about the French health market:

Funding in the French healthcare system

In France there is mandatory enrolment in a statutory health insurance system. This covers most costs for hospital, physician, and long-term care, as well as prescription drugs.

Patients are responsible for co-insurance and co-payments, balancing bills for physician charges that exceed covered fees.

Health technology assessment in the France

The French domestic market for pharmaceuticals is highly regulated, with continued pressure from the French public health authorities to lower sales costs of drugs and medicines for end consumers.

The Haute Autorité de Santé (HAS) are responsible for the evaluation of pharmaceuticals and medical devices, and define both SMR and ASMR scores, which impact on pricing and reimbursement decision . However, medical devices have a range of reimbursement processes available, including a fast-track reimbursement process introduced in June 2023.

French payers’ primary focus:

The French market is clinically focused.

To discuss your launch strategy for France with our experts, or to enquire about market research services, get in touch using the form below.

    Keep me up to date with the latest news and events.

    US and European market access for medical devices – free guide

    US and European Market Access for Medical Devices – Free Guide

    We are delighted to announce that the second edition of our popular introductory guide: ‘Market access stakeholders and processes for medical devices in key European markets’ is now available…

    EU Joint Clinical Assessment (JCA) – implications for Pharma and Medtech cover

    EU Joint Clinical Assessment (JCA) – implications for Pharma and Medtech

    Our health technology assessment experts provide an overview of the EU Joint Clinical Assessment (JCA) and what it means for Pharma and Medical Device manufacturers launching new technologies from 2025

    Market access and reimbursement in key European markets

    Market access and reimbursement in key European markets

    In this introductory guide, our Global market access experts present an overview of the reimbursement landscape in key European healthcare systems, including Germany.